Click on the links below to access PDFs of key Oncotype DX® assay health-economics-related publications.
Economic Analysis of Targeting Chemotherapy Using a 21-Gene RT-PCR Assay in Lymph Node-Negative, Estrogen Receptor-Positive, Early-Stage Breast Cancer J Hornberger, LE Cosler, GH Lyman Am J Manag Care. 2005; 11(5):313-324.
Impact of a 21-Gene RT-PCR Assay on Treatment Decisions in Early-Stage Breast Cancer, An Economic Analysis Based on Prognostic and Predictive Validation Studies GH Lyman, LE Cosler, NM Kuderer, J Hornberger Cancer. 2007; 109(6):1011-1018.